News & partners

Dianosic is a biotech focused on the development of novel solutions integrated drug and
delivery system for the localized treatment of patients with chronic rhinitis and chronic rhinosinusitis.

Latest news

Apr 22, 2020

Le journal des entreprises

See more
Apr 22, 2020

Dianosic closes first funding round of €1.5M

See more

They support us

Our investors

We built a solid network of partners to support company funding and growth.

Fondation Force
Bpi France
Banque Populaire Rives de Paris
Caisse d’épargne Grand Est